Cardiff Oncology, Inc. (CRDF)

NASDAQ: CRDF · Real-Time Price · USD

1.600

+0.050 (3.23%)

At close: Feb 11, 2026, 4:00 PM EST

1.618

+0.018 (1.13%)

After-hours: Feb 11, 2026, 7:51 PM EST

Cardiff Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	108	289	66	63	252	635
Market Cap Growth	-38.20%	336.64%	5.71%	-75.20%	-60.31%	6519.33%
Enterprise Value	48	233	-13	-49	121	600
Last Close Price	1.60	4.34	1.48	1.40	6.01	17.99
PS Ratio	202.92	422.72	135.50	162.04	702.51	1736.31
PB Ratio	2.20	3.48	0.95	0.59	1.80	4.96
P/TBV Ratio	2.21	3.48	0.95	0.59	1.80	4.96
EV/Sales Ratio	96.20	340.75	-	-	338.28	1640.66
Debt / Equity Ratio	0.02	0.02	0.03	0.03	0.02	0.01
Asset Turnover	0.01	0.01	0.01	0.00	0.00	0.01
Quick Ratio	4.14	6.92	7.25	13.58	21.55	21.46
Current Ratio	4.20	7.08	7.42	14.25	22.28	21.79
Return on Equity (ROE)	-102.71%	-59.51%	-47.07%	-31.37%	-21.07%	-28.50%
Return on Assets (ROA)	-52.99%	-34.01%	-28.69%	-18.77%	-12.69%	-16.14%
Return on Capital Employed (ROCE)	-109.40%	-58.10%	-63.80%	-36.80%	-20.20%	-14.80%
Earnings Yield	-46.81%	-15.74%	-62.67%	-61.88%	-11.22%	-3.04%
FCF Yield	-39.22%	-13.08%	-47.59%	-55.68%	-9.22%	-2.60%
Buyback Yield / Dilution	-40.37%	-6.65%	-2.47%	-11.71%	-86.97%	-249.44%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q